Over 1,750 Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer lower insulin costs through the Part D Senior Savings Model for the 2021 plan year, the Centers for Medicare & Medicaid Services said yesterday.

Announced in March, the five-year model will require participating plans to limit cost sharing for a 30-day supply of insulin to no more than $35. CMS estimates beneficiaries in the plans could save an average $446 (66%) in out-of-pocket costs for insulin, funded in part by manufacturer discounts. Part D sponsors that applied must submit their calendar year 2021 plan benefits to CMS by June 1. CMS expects to release CY 2021 premiums and costs for specific Medicare plans in September, including final information on the model.

Headline
The AHA shared the following statement with the media in response to a report released May 7 by Families USA.   “This report is long on rhetoric and…
Headline
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S. 4384), bipartisan and bicameral…
Headline
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible…
Headline
The AHA today submitted comments on the Centers for Medicare & Medicaid Services’ proposed revisions to Medicare Advantage and Part D reporting…
Headline
The Centers for Medicare & Medicaid Services has begun collecting private payor rate data through its Fee-for-Service Data Collection System Clinical Lab…
Headline
Sens. Chuck Grassley, R-Iowa, and Michael Bennet, D-Colo., April 30 introduced the Rural Community Hospital Demonstration Reauthorization Act, legislation that…